Business Wire

ALIBABA-CLOUD

2.11.2022 08:01:35 CET | Business Wire | Press release

Share
Alibaba Cloud Showcases Wuying Cloudbook at Apsara Conference

Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, will be showcasing the new additions to its cloud computer offering at its Apsara Conference. The Wuying Cloudbook, empowered by Wuying Architecture, is designed to provide enterprises with unlimited computing power while helping them enhance data security, improve cost efficiency and facilitate collaboration in increasingly diverse hybrid office settings.

Drawing on the high levels of security, scalability and compatibility that characterize the cloud, the Wuying Cloudbook allows users to fully leverage the power of cloud computing while minimizing the workload for local devices. Users can scale computing power and storage up or down to meet their demands as and when they need, getting rid of the capacity restrictions of running large-scale software, such as video-rendering software, and enjoying a real-time interactive experience with low latency and high-quality images.

Wuying Cloudbook supports secure storage and transmission of massive volumes of organizational resources by centralizing and managing them in the cloud. It overcomes typical security challenges in enterprise environments, such as data loss and local device vulnerabilities, while allowing users to access organizational resources at any time, anywhere.

Wuying Cloudbook also extends the boundaries of collaboration, allowing users to run multiple operating systems, including Windows, Linux, or Android on it simultaneously. As the software is also deployed and running in the cloud, there is no need to download and install software on local devices, minimizing the requirement for storage capacity and the battery consumption of local devices. Wuying Cloudbook is an ideal choice for new ways of working, such as remote working, outsourcing, and collaboration between teams in different locations.

The scalability, security and flexibility of Wuying Cloudbook is supported by Alibaba Cloud’s Wuying Architecture, which is designed to optimize workload collaboration between cloud and local devices. The industry-leading architecture is compatible with devices ranging from laptops and tablets to any hardware that demands robust computing power. Leveraging this architecture, users can access unlimited computing power and storage capacity in any computing terminal.

Wuying Architecture is a powerful extension and expansion of the workplace. It helps enterprises to enhance flexibility and improve operational efficiency. Taking advantage of cloud-based data security capabilities and tools, Wuying provides additional assurance to safeguarding corporate information security,” said Jiangwei JIANG, Senior Researcher and General Manager of Infrastructure Products, Alibaba Cloud Intelligence. “Thanks to its compatibility, Wuying Architecture brings the benefits of cloud computing to hardware brands, software vendors and enterprises, as well as individual users.”

The Wuying Cloudbook, will be demonstrated at the exhibition area at Alibaba Cloud’s Apsara Conference, features an ultra-thin body just 13.9mm deep and a 14-inch touch-screen. An unboxing video, giving a preview of the device, is available here. With this new addition, Alibaba Cloud now offers cloud computing in the form of a card, a box, an all-in-one PC, a laptop and a Desktop-as-a Service (DaaS) application.

Customer experiences with Wuying: Automotive and Education

In China, IM Motors, an intelligent electric vehicle company, is the first in the automobile industry to adopt Wuying in product design. At the R&D stage, teams in different locations need to collaborate closely. Using Wuying, the design documents can be accessed by multiple teams in multiple locations.

“The automobile industry traditionally relied heavily on offline collaboration, as large-scale workstations were necessary for many work processes. Wuying is a dream come true for our sector. Not only does it offer the necessary computing power to support the intense workload, but it also eases our anxiety around data security when transmitting and sharing confidential design files, allowing us to focus our attention on the design itself,” said Jiao XIANG, Executive Director of Intelligence Research Center, IM Motors.

East China Normal University is one of the early adopters of Wuying in education. The cloud computer has replaced traditional server rooms in research projects, allowing students to work seamlessly on their projects when they move from laboratories to classrooms and dormitories, as the research data has been centralized in the cloud. Research efficiency has also been greatly improved by running data analytics on the cloud.

“This mobile research mode offered by Wuying has proven to be very valuable for professors and students alike. On-the-cloud laboratories provide unlimited computing power, overcoming the limitations of latency and bandwidth in a localized setting. In addition, it’s a powerful, 24/7 service, which helps us obtain research results in a much shorter time,” said Wei WANG, professor of the School of Data Science and Engineering, East China Normal University.

Apsara Conference opens tomorrow

As well as showcasing the Wuying Cloudbook, Alibaba Cloud’s annual Apsara Conference, which opens on November 3 in Hangzhou and runs until November 5, will shed light on the tech leader’s business strategy, products and partnerships.

About Alibaba Cloud

Established in 2009, Alibaba Cloud (www.alibabacloud.com) is the digital technology and intelligence backbone of Alibaba Group. It offers a complete suite of cloud services to customers worldwide, including elastic computing, database, storage, network virtualization services, large-scale computing, security, management and application services, big data analytics, a machine learning platform and IoT services. Alibaba maintained its position as the third leading public cloud IaaS service provider globally since 2018, according to IDC. Alibaba is the world’s third leading and Asia Pacific’s leading IaaS provider by revenue in U.S. dollars since 2018, according to Gartner.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221101006400/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release

SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag

Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release

Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a

Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release

Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release

GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc

Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 07:00:00 CET | Press release

Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new produ

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye